44 related articles for article (PubMed ID: 18248561)
21. Immunohistochemically defined subtypes and outcome of apocrine breast cancer.
Dellapasqua S; Maisonneuve P; Viale G; Pruneri G; Mazzarol G; Ghisini R; Mazza M; Iorfida M; Rotmensz N; Veronesi P; Luini A; Goldhirsch A; Colleoni M
Clin Breast Cancer; 2013 Apr; 13(2):95-102. PubMed ID: 23245877
[TBL] [Abstract][Full Text] [Related]
22. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
23. 'Pure' invasive apocrine carcinoma of the breast: a new clinicopathological entity?
Japaze H; Emina J; Diaz C; Schwam RJ; Gercovich N; Demonty G; Morgenfeld E; Rivarola E; Gil Deza E; Gercovich FG
Breast; 2005 Feb; 14(1):3-10. PubMed ID: 15695074
[TBL] [Abstract][Full Text] [Related]
24. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
25. Clinical-pathologic features and long-term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapy.
Liu GF; Yang Q; Haffty BG; Moran MS
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1304-8. PubMed ID: 19386432
[TBL] [Abstract][Full Text] [Related]
26. [Ten cases of an apocrine carcinoma of the breast and a review of cases in the Japanese literature].
Aoyagi H; Ishida T; Yamada I; Kurebayashi J; Kurosumi M; Yokoe T; Ogawa T; Kawai T; Izuo M
Gan No Rinsho; 1990 May; 36(6):681-90. PubMed ID: 2190018
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia.
Celis JE; Gromova I; Gromov P; Moreira JM; Cabezón T; Friis E; Rank F
FEBS Lett; 2006 May; 580(12):2935-44. PubMed ID: 16631754
[TBL] [Abstract][Full Text] [Related]
28. An update on apocrine lesions of the breast.
O'Malley FP; Bane A
Histopathology; 2008 Jan; 52(1):3-10. PubMed ID: 18171412
[TBL] [Abstract][Full Text] [Related]
29. Apocrine carcinoma of the breast: a comprehensive review.
Vranic S; Schmitt F; Sapino A; Costa JL; Reddy S; Castro M; Gatalica Z
Histol Histopathol; 2013 Nov; 28(11):1393-409. PubMed ID: 23771415
[TBL] [Abstract][Full Text] [Related]
30. [Recurrent pigmented epidermotropic infiltrating breast ductular carcinoma simulating melanoma].
Belousova IE; Kazakov DV; Man'iakova T; Mikcal M
Arkh Patol; 2006; 68(6):44-6. PubMed ID: 17290896
[TBL] [Abstract][Full Text] [Related]
31. Intraductal carcinoma of prostate (IDC-P): from obscure to significant.
Chen N; Zhou Q
Chin J Cancer Res; 2016 Feb; 28(1):99-106. PubMed ID: 27041932
[TBL] [Abstract][Full Text] [Related]
32. The lymphatics in infiltrating ductal carcinoma (IDC) of the breast.
van Netten JP; Cann SH; Thornton IG; Finegan RP
Cancer Treat Rev; 2018 Jan; 62():97. PubMed ID: 29183000
[No Abstract] [Full Text] [Related]
33. Invasive apocrine carcinoma of the breast: clinicopathologic features of 57 patients.
Tanaka K; Imoto S; Wada N; Sakemura N; Hasebe K
Breast J; 2008; 14(2):164-8. PubMed ID: 18248561
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
